{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:44:51Z","timestamp":1788893091955,"version":"build-2803163510"},"reference-count":38,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hashimoto thyroiditis (HT) is a prevalent autoimmune thyroid disease characterized by lymphocytic infiltration and autoantibody production. Our previous findings showed that enhancer of zeste homolog 2 (EZH2) and BACH transcriptional regulator 2 (BACH2) are upregulated in HT thyroid tissues. However, the role of EZH2 in B-cell\u2013mediated autoimmunity remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate how EZH2 regulates B-cell responses in a spontaneous autoimmune thyroiditis (SAT) mouse model and to explore potential downstream epigenetic mechanisms, including BACH2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A NOD.H-2h4 mouse model of SAT was used to assess the effect of the EZH2 catalytic activity inhibitor GSK126 on thyroid inflammation and B-cell responses. The human B-lymphocyte cell line GM12878 underwent EZH2 knockdown or was treated with GSK126 to evaluate BACH2 expression, H3K27me3 levels, and IgG secretion. Chromatin immunoprecipitation followed by quantitative polymerase chain reaction (ChIP-qPCR) and luciferase assays were employed to examine EZH2-dependent regulation of BACH2, and rescue experiments were conducted using BACH2 overexpression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In SAT mice, GSK126 reduced thyroid lymphocytic infiltration, decreased CD19+ and IgG+ B-cell infiltration, and lowered thyroidal IgG and serum IgG levels. In vitro, pharmacological inhibition of EZH2 catalytic activity or knockdown suppressed BACH2, reduced H3K27me3, and diminished IgG secretion. Luciferase and ChIP-qPCR assays supported EZH2-dependent regulation of BACH2, and BACH2 overexpression partially restored BACH2 expression but did not fully rescue IgG production after EZH2 methyltransferase activity inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EZH2 contributes to B-cell\u2013mediated immune responses and IgG production through epigenetic mechanisms in SAT. BACH2 may represent one downstream target of EZH2, but additional pathways are likely involved.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/endocr\/bqag096","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:20:37Z","timestamp":1788175237000},"source":"Crossref","is-referenced-by-count":1,"title":["Enhancer of zeste homolog 2 regulates B-cell responses in a NOD.H-2h4 model of spontaneous autoimmune thyroiditis"],"prefix":"10.1210","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0209-7323","authenticated-orcid":false,"given":"Shengguo","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinnan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedi","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-3859","authenticated-orcid":false,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxue","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-9483","authenticated-orcid":false,"given":"Ying","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital , Beijing 100034 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"10","key":"2026090804164805700_bqag096-B1","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2026090804164805700_bqag096-B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"2026090804164805700_bqag096-B3","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.3390\/ijms25136883","article-title":"The role of the immune system in the course of Hashimoto's thyroiditis: the current state of knowledge","volume":"25","author":"Wronska","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026090804164805700_bqag096-B4","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70153","article-title":"Construction of the single-cell landscape of Hashimoto's thyroiditis tissue and peripheral blood by single-cell RNA sequencing","volume":"13","author":"Song","year":"2025","journal-title":"Immun Inflamm Dis"},{"issue":"10","key":"2026090804164805700_bqag096-B5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.autrev.2018.05.004","article-title":"New insights into the etiopathogenesis of Hashimoto's thyroiditis: the role of genetics and epigenetics","volume":"17","author":"Ralli","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2026090804164805700_bqag096-B6","first-page":"396","article-title":"The emerging role of epigenetics in autoimmune thyroid diseases","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"2026090804164805700_bqag096-B7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"10","key":"2026090804164805700_bqag096-B8","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.celrep.2018.11.035","article-title":"Polycomb- and methylation-independent roles of EZH2 as a transcription activator","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Rep"},{"issue":"3","key":"2026090804164805700_bqag096-B9","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.18632\/oncotarget.6198","article-title":"EZH2 in normal hematopoiesis and hematological malignancies","volume":"7","author":"Herviou","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"2026090804164805700_bqag096-B10","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1172\/JCI134217","article-title":"The CDK4\/6-EZH2 pathway is a potential therapeutic target for psoriasis","volume":"130","author":"Muller","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"2026090804164805700_bqag096-B11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.20171417","article-title":"Macrophage\/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3","volume":"215","author":"Zhang","year":"2018","journal-title":"J Exp Med"},{"key":"2026090804164805700_bqag096-B12","article-title":"EZH2 inhibition interferes with the activation of type I interferon signaling pathway and ameliorates lupus nephritis in NZB\/NZW F1 mice","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"2026090804164805700_bqag096-B13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.41208","article-title":"Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase EZH2","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2026090804164805700_bqag096-B14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-020-02225-9","article-title":"Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease","volume":"22","author":"Zhen","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"2026090804164805700_bqag096-B15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41590-024-01900-2","article-title":"Epigenetic recording of stimulation history reveals BLIMP1-BACH2 balance in determining memory B cell fate upon recall challenge","volume":"25","author":"Shao","year":"2024","journal-title":"Nat Immunol"},{"issue":"1","key":"2026090804164805700_bqag096-B16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41577-023-00897-3","article-title":"Memory B cells","volume":"24","author":"Inoue","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"6991","key":"2026090804164805700_bqag096-B17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature02596","article-title":"The transcriptional programme of antibody class switching involves the repressor Bach2","volume":"429","author":"Muto","year":"2004","journal-title":"Nature"},{"issue":"21","key":"2026090804164805700_bqag096-B18","first-page":"2639","article-title":"EZH2 expression in B cell lymphocyte subsets of Hashimoto's thyroiditis and the therapeutic mechanism and effect of its inhibitors","volume":"27","author":"Yi","year":"2024","journal-title":"Chin Gen Pract"},{"issue":"6","key":"2026090804164805700_bqag096-B19","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103783","article-title":"The immune system in Hashimoto's thyroiditis: updating the current state of knowledge on potential therapies and animal model construction","volume":"24","author":"Li","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2026090804164805700_bqag096-B20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/thy.2022.0448","article-title":"Severe autoimmune thyroiditis in transgenic NOD.H2(h4) mice expressing interleukin-4 in the thyroid","volume":"33","author":"Merakchi","year":"2023","journal-title":"Thyroid"},{"issue":"12","key":"2026090804164805700_bqag096-B21","first-page":"1645","article-title":"Pharmacological advancements of PRC2 in cancer therapy: a narrative review","volume":"14","author":"Wang","year":"2024","journal-title":"Life (Basel)"},{"key":"2026090804164805700_bqag096-B22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116624","article-title":"EZH2: the roles in targeted therapy and mechanisms of resistance in breast cancer","volume":"175","author":"Chen","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"7427","key":"2026090804164805700_bqag096-B23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"2026090804164805700_bqag096-B24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2018.02.006","article-title":"Estrogen receptor \u03b2 activation stimulates the development of experimental autoimmune thyroiditis through up-regulation of Th17-type responses","volume":"190","author":"Qin","year":"2018","journal-title":"Clin Immunol"},{"issue":"3","key":"2026090804164805700_bqag096-B25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/clinem\/dgad588","article-title":"Gut microecology may be involved in the pathogenesis of Hashimoto thyroiditis by reducing production of hydrogen sulfide","volume":"109","author":"Zhang","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090804164805700_bqag096-B26","doi-asserted-by":"crossref","unstructured":"Yi S, Li X, Cao Y, et al \u00a02026. Supplementary material for \u201cEnhancer of zeste homolog 2 regulates B-cell responses in a NOD.H-2h4 model of spontaneous autoimmune thyroiditis\u201d. Figshare. 10.6084\/m9.figshare.33116936.","DOI":"10.1210\/endocr\/bqag096"},{"key":"2026090804164805700_bqag096-B27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108636","article-title":"Diversity of complement activation in different thyroid diseases","volume":"106","author":"Zhao","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2026090804164805700_bqag096-B28","article-title":"IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway","volume":"13","author":"Zhao","year":"2024","journal-title":"Eur Thyroid J"},{"issue":"6113","key":"2026090804164805700_bqag096-B29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"issue":"5","key":"2026090804164805700_bqag096-B30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.smim.2011.08.010","article-title":"The genetic network controlling plasma cell differentiation","volume":"23","author":"Nutt","year":"2011","journal-title":"Semin Immunol"},{"issue":"5","key":"2026090804164805700_bqag096-B31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4049\/jimmunol.2100172","article-title":"Continuous culture of mouse primary B lymphocytes by forced expression of Bach2","volume":"207","author":"Finney","year":"2021","journal-title":"J Immunol"},{"key":"2026090804164805700_bqag096-B32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3389\/fimmu.2014.00596","article-title":"Regulation of germinal center, B-cell memory, and plasma cell formation by histone modifiers","volume":"5","author":"Good-Jacobson","year":"2014","journal-title":"Front Immunol"},{"issue":"2","key":"2026090804164805700_bqag096-B33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement","volume":"4","author":"Su","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"2026090804164805700_bqag096-B34","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/s41467-019-10176-2","article-title":"Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"2026090804164805700_bqag096-B35","first-page":"501","article-title":"Experimental investigation on iodine-induced autoimmune thyroiditis in NOD.H-2h4 mice","volume":"23","author":"Teng","year":"2007","journal-title":"Chin J Endocrinol Metab"},{"key":"2026090804164805700_bqag096-B36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676686","article-title":"Memory B cells in multiple sclerosis: emerging players in disease pathogenesis","volume":"12","author":"DiSano","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"2026090804164805700_bqag096-B37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/clin.1996.0191","article-title":"Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice","volume":"81","author":"Rasooly","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"2026090804164805700_bqag096-B38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1210\/en.2004-1126","article-title":"Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice","volume":"146","author":"McLachlan","year":"2005","journal-title":"Endocrinology"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag096\/70878857\/bqag096.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/10\/bqag096\/70878857\/bqag096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/10\/bqag096\/70878857\/bqag096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:16:57Z","timestamp":1788855417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag096\/8776358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag096","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,31]]},"article-number":"bqag096"}}